Suppr超能文献

预测根治性肝切除术后肝细胞癌患者总生存期的模型

Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy.

作者信息

Zhang Li-Xiang, Luo Pan-Quan, Chen Lei, Song Dong-da, Xu A-Man, Xu Peng, Xu Jia

机构信息

Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Department of General Surgery, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China.

出版信息

Front Oncol. 2021 Mar 5;10:537526. doi: 10.3389/fonc.2020.537526. eCollection 2020.

Abstract

BACKGROUND

The prognosis of patients with hepatocellular carcinoma (HCC) remains difficult to accurately predict. The purpose of this study was to establish a prognostic model for HCC based on a novel scoring system.

METHODS

Five hundred and sixty patients who underwent a curative hepatectomy for treatment of HCC at our hospital between January 2007 and January 2014 were included in this study. Univariate and multivariate analyses were used to screen for prognostic risk factors. The nomogram construction was based on Cox proportional hazard regression models, and the development of the new scoring model was analyzed using receiver operating characteristic (ROC) curve analysis and then compared with other clinical indexes. The novel scoring system was then validated with an external dataset from a different medical institution.

RESULTS

Multivariate analysis showed that tumor size, portal vein tumor thrombus (PVTT), invasion of adjacent tissues, microvascular invasion, and levels of fibrinogen and total bilirubin were independent prognostic factors. The new scoring model had higher area under the curve (AUC) values compared to other systems, and the C-index of the nomogram was highly consistent for evaluating the survival of HCC patients in the validation and training datasets, as well as the external validation dataset.

CONCLUSIONS

Based on serum markers and other clinical indicators, a precise model to predict the prognosis of patients with HCC was developed. This novel scoring system can be an effective tool for both surgeons and patients.

摘要

背景

肝细胞癌(HCC)患者的预后仍然难以准确预测。本研究的目的是基于一种新的评分系统建立HCC的预后模型。

方法

本研究纳入了2007年1月至2014年1月期间在我院接受根治性肝切除术治疗HCC的560例患者。采用单因素和多因素分析筛选预后危险因素。列线图构建基于Cox比例风险回归模型,并使用受试者工作特征(ROC)曲线分析来分析新评分模型的开发情况,然后与其他临床指标进行比较。然后使用来自不同医疗机构的外部数据集对新评分系统进行验证。

结果

多因素分析表明,肿瘤大小、门静脉癌栓(PVTT)、邻近组织侵犯、微血管侵犯以及纤维蛋白原和总胆红素水平是独立的预后因素。与其他系统相比,新评分模型的曲线下面积(AUC)值更高,列线图的C指数在验证数据集、训练数据集以及外部验证数据集中评估HCC患者的生存率时高度一致。

结论

基于血清标志物和其他临床指标,开发了一种精确的模型来预测HCC患者的预后。这种新的评分系统可以成为外科医生和患者的有效工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/7977285/9e3407e19b08/fonc-10-537526-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验